(lp0
S'Analysts Expecting Positive Results from Imprimis Pharmaceuticals, Inc ... StockNewsUnion - 10 hours ago Imprimis Pharmaceuticals, Inc.  shares were trading below $2.50 last week. Today IMMY shares are trading above $3.80 on exceptionally heavy volumes - over thirty times their daily average.Lookout for Price Target? Imprimis Pharmaceuticals, Inc. , ACI Worldwide ... - StockNewsJournalImprimis Pharmaceuticals Inc  Rating Increased to Buy at Zacks ... - The Cerbat Gem'
p1
aS'Imprimis Pharmaceuticals to Raise $3.1 Million in Registered Direct Offering Yahoo Finance - Mar 22, 2017 SAN DIEGO, March 22, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , an ophthalmology-focused pharmaceutical company, announced today that it has entered into agreements with two accredited investors for a registered direct placement of&nbsp;...Imprimis Pharmaceuticals, Inc.  Files An 8-K Entry into a ... - Market ExclusiveImprimis Pharmaceuticals Inc.  Analyst Rating Dulls Dilutive ... - StockNewsUnion'
p2
aS'Imprimis Pharmaceuticals Announces Availability of Lower-Cost Option for the ... PR Newswire  - Oct 17, 2016 SAN DIEGO, Oct. 17, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high quality innovative compounded medications, today announced the availability of a&nbsp;...'
p3
aS"Imprimis Pharmaceuticals Announces $9.8 Million Private Placement of Units PR Newswire  - Dec 19, 2016 SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.  today announced that it has entered into a definitive securities purchase agreement with various accredited investors and certain members of Imprimis' Board of&nbsp;..."
p4
aS'Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B ... PR Newswire  - Feb 16, 2017 SAN DIEGO, Feb. 16, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , an ophthalmology-focused pharmaceutical company, today announced that it has begun shipping its core sterile ophthalmic medications to select customers from&nbsp;...'
p5
aS'Imprimis Pharmaceuticals Announces Plans to Register its Texas Pharmacy with ... PR Newswire  - Oct 29, 2015 SAN DIEGO, Oct. 29, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, announced that it has&nbsp;...'
p6
aS'Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2016 ... Yahoo Finance - Mar 7, 2017 SAN DIEGO, March 7, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , an ophthalmology-focused pharmaceutical company, today reported it will release fourth quarter and fiscal year 2016 financial results after the close of trading on Tuesday,&nbsp;...'
p7
aS'Imprimis Pharmaceuticals Registers its Texas Facility with the FDA as an ... PR Newswire  - Apr 12, 2016 SAN DIEGO, April 12, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the development and commercialization of proprietary and customizable drug formulations, announced today that it has filed&nbsp;...'
p8
aS"Imprimis Pharmaceuticals' Formulations to be Highlighted at Upcoming Annual ... PR Newswire  - Oct 13, 2016 SAN DIEGO, Oct. 13, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high-quality innovative compounded medications, today announced events featuring its&nbsp;..."
p9
aS'Imprimis Pharmaceuticals Announces Plans to Launch IV Free Conscious ... PR Newswire  - May 5, 2016 SAN DIEGO, May 5, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the development and commercialization of proprietary and customizable drug formulations, today announced plans to launch&nbsp;...'
p10
a.